The Alteration Of Er Beta 5 And Collagen Metabolism Is Relevant To The Development Of Stress Urinary Incontinence

Min Wang,Caiqin Wang,Xiufeng Huang,Guangyong Ye

2019-01-01

Abstract:The primary purpose of this study was to identify the predominant isoform of ER beta responsible for the development of stress urinary incontinence (SUI). In this study, anterior vaginal wall tissues were taken from five SUI patients and five women who served as a control. Fibroblast cells were isolated from the tissues and treated with the selective ERr3 antagonist (4-[2-phenyl-5,7-bis(trifluoromethyl) pyrazolo [1,5-a]pyrimidin-3-yl]phenol, PHTPP) or the agonist (diarylpropionitrile, DPN). The quantitative real-time PCR method was used to detect the mRNA expressions of ER beta (ER beta 1, 2, 3, and 5), MMP-1, TIMP-1, and collagens I and III. Immunohistochemistry staining was used to detect the protein expressions of ER beta 5, MMP-1, TIMP-1, and collagens I and III. An enzyme-linked immunosorbent assay (EUSA) was used to detect the protein expressions of collagens I and III. The MTT method was used to determine the viability of fibroblast cells. Our results showed that it was the ER beta 5 rather than the ER beta 1, ER beta 2, or ER beta 3 that significantly decreased in the SUI patients. Alteration of collagen metabolism was noticed in the SUI patients characterized by a decrease of collagen I, collagen III, and TIMP-1 and an increase of MMP-1. An in vitro study showed that the mRNA and protein expressions of ER beta 5, collagen I, collagen III, and TIMP-1 were decreased, and MMP-1 was increased after PHTPP treatment. The four measurements were changed in the opposite direction after DPN treatment. These results suggested that the alteration of ER beta 5 and collagen metabolism may be relevant to the development of SUI, so ER beta 5 is a potential target for SUI treatment.